(GEHC) GE HealthCare Technologies - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US36266G1076
GEHC: Imaging, Ultrasound, Scanners, Monitors, Agents, Devices
GE HealthCare Technologies Inc. (GEHC) stands as a leader in the healthcare technology sector, offering a comprehensive suite of products and services that cater to the diagnosis, treatment, and monitoring of patients globally. Their operations are divided into four key segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics, each playing a crucial role in modern healthcare.
The Imaging segment is pivotal, providing advanced diagnostic tools such as CT scanners, MRI machines, and X-ray systems, which are essential for accurate patient care. This segment positions GEHC as a one-stop-shop for healthcare providers seeking diverse imaging solutions. Additionally, their focus on womens health products underscores their commitment to addressing specific patient needs.
The Ultrasound segment offers innovative devices used across various clinical areas, including radiology, primary care, and cardiovascular health. Their point-of-care and handheld solutions reflect an understanding of the evolving needs in healthcare delivery, particularly in remote and resource-limited settings. This adaptability is a testament to
Additional Sources for GEHC Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
GEHC Stock Overview
| Market Cap in USD | 32,925m |
| Sector | Healthcare |
| Industry | Health Information Services |
| GiC Sub-Industry | Health Care Equipment |
| IPO / Inception | 2023-01-04 |
GEHC Stock Ratings
| Growth Rating | 14.9 |
| Fundamental | 50.6 |
| Dividend Rating | 43.2 |
| Rel. Strength | -26.1 |
| Analysts | 4.15/5 |
| Fair Price Momentum | 50.98 USD |
| Fair Price DCF | 74.50 USD |
GEHC Dividends
| Dividend Yield 12m | 0.13% |
| Yield on Cost 5y | 0.16% |
| Annual Growth 5y | 15.47% |
| Payout Consistency | 100.0% |
GEHC Growth Ratios
| Growth Correlation 3m | -83.2% |
| Growth Correlation 12m | 20.1% |
| Growth Correlation 5y | 56.9% |
| CAGR 5y | 1.81% |
| CAGR/Max DD 5y | 0.05 |
| Sharpe Ratio 12m | -0.86 |
| Alpha | -33.56 |
| Beta | 1.126 |
| Volatility | 48.31% |
| Current Volume | 4474k |
| Average Volume 20d | 4685.1k |
As of April 19, 2025, the stock is trading at USD 62.37 with a total of 4,473,983 shares traded.
Over the past week, the price has changed by -0.70%, over one month by -24.07%, over three months by -28.59% and over the past year by -26.52%.
Partly, yes. Based on ValueRay Fundamental Analyses, GE HealthCare Technologies (NASDAQ:GEHC) is currently (April 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 50.56 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GEHC as of April 2025 is 50.98. This means that GEHC is currently overvalued and has a potential downside of -18.26%.
GE HealthCare Technologies has received a consensus analysts rating of 4.15. Therefor, it is recommend to buy GEHC.
- Strong Buy: 11
- Buy: 3
- Hold: 5
- Sell: 0
- Strong Sell: 1
According to ValueRays Forecast Model, GEHC GE HealthCare Technologies will be worth about 56 in April 2026. The stock is currently trading at 62.37. This means that the stock has a potential downside of -10.18%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 100.2 | 60.6% |
| Analysts Target Price | 96.8 | 55.1% |
| ValueRay Target Price | 56 | -10.2% |